(Stock Code 股份代號: 3600) NOTIFICATION LETTER 通知信函 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） It is the responsibility of registered shareholders to provide a functional email address. If you have not provided your email address to the Company or need to update your email address, the Company recommends you to provide your email address by completing, signing the enclosed Change Request Form and returning to the Branch Share Registrar at the above-mentioned address by post or ...

茲通告現代牙科集團有限公司（「本公司」）將於2025年5月29日（星期四）下午二時三十 分假座香港九龍長沙灣永康街77號環薈中心17樓1701-07室舉行股東周年大會（「大會」） 以： 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 （於開曼群島註冊成立的有限公司） （股份代號：3600） 股東周年大會通告 普通決議案 「動議： (a) 在遵守香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市規則」）現行 要求的前提及下文(b)段規限下，一般及無條件批准本公司董事（「董事」）於有 關期間（定義見下文）內行使本公司全部權力根據所有適用法律、守則及法規 購回其股份； – 1 – 1. 省覽及考慮截至2024年12月31日止年度之經審核綜合財務報表及本公司董事會 報告及核數師報告。 2. 自本公司股份溢價賬宣派末期股息。 3. (a) (i) 重選陳奕茹女士為本公司執行董事。 (ii) 重選陳志遠先生為本公司執行董事。 (iii) 重選邱家寶醫生為本 ...

此乃要件 請即處理 閣下對本通函之任何方面或該採取的行動如有任何疑問，應諮詢股票經紀或其他註冊證券 商、銀行經理、律師、專業會計師或其他專業顧問。 閣下如已售出或轉讓名下所有之現代牙科集團有限公司股份，應立即將本通函及隨附之委 任代表表格送交買主、承讓人或送交經手買賣或轉讓之銀行、股票經紀或其他代理商，以 便轉交買主或承讓人。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函之內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示概不就因本通函全部或任何部份內容而產生 或因依賴該等內容而引致之任何損失承擔任何責任。 MODERN DENTAL GROUP LIMITED （於開曼群島註冊成立的有限公司） （股份代號：3600） 建議重選董事 及 建議授出購回股份 及發行股份之一般授權 及 建議自股份溢價賬派付末期股息 及 股東周年大會通告 現代牙科集團有限公司謹訂於2025年5月29日（星期四）下午二時三十分假座香港九龍長沙 灣永康街77號環薈中心17樓1701-07室舉行股東周年大會，大會通告載於本通函。 無論 閣下能否出席股東周年大會，務請按照隨附股東周年大會適用的代表委任表格印備 的指示 ...

目 錄 關於本報告 緒言 可持續發展管治 權益人參與 重要性評估 環境層面 環保產品和服務 排放物 資源使用 環境及天然資源 氣候變化 社會層面 人才吸納及挽留 健康與安全 發展及培訓 營運常規 社區 附錄一 關鍵績效指標概覽 附錄二 會籍與約章 附錄三 《環境 、社會及管治報告指引 》內容索引 附錄四 全球報告倡議準則內容索引 附錄五 氣候相關財務披露索引 24579 12 13 14 15 16 23 25 26 28 34 40 43 43 48 53 現代牙科集團有限公司 關於本報告 現代牙科集團有限公司（「本公司」，連同其附屬公司統稱「本集團」）欣然呈列截至2024年12月31日止年度環境、社會 及管治報告（「本報告」），當中概述我們透過我們的可持續性優勢實現環境、社會及管治目標的承諾。董事（「董事」，各 自為一名「董事」）會（「董事會」）對本集團的環境、社會及管治策略及報告負有全部責任。董事會負責評估及釐定本集團 有關環境、社會及管治的風險，並確保設有適當有效的環境、社會及管治風險管理與內部控制系統。本報告由本集團 在外部專業服務公司的協助下編製。 報告期 本報告說明我們於2024年1月1日至20 ...

Financial Performance - For the fiscal year ending December 31, 2024, the company reported revenue of approximately HKD 3,364 million, an increase of about 6.1% compared to HKD 3,172 million in 2023[22]. - The gross profit margin for the same period was approximately 53.5%, with gross profit amounting to HKD 1,798 million, reflecting a 5.8% increase from HKD 1,700 million in 2023[22]. - Adjusted EBITDA for the fiscal year was approximately HKD 741 million, marking a historical high and an increase of about 2.1% from HKD 694 million in 2023[22]. - The net profit for the fiscal year was approximately HKD 406 million, a 1.2% increase from HKD 402 million in 2023[22]. - The adjusted EBITDA for the year ended December 31, 2024, was approximately HKD 741,481,000, an increase of about HKD 47,582,000 or 6.9% compared to 2023[26]. - Core business profit for the year ended December 31, 2024, was approximately HKD 434,982,000, reflecting an increase of about HKD 33,377,000 or 8.3% from 2023[26]. - Basic earnings per share for the year ended December 31, 2024, were HKD 0.432, up approximately 1.9% from HKD 0.424 in 2023[26]. - The total revenue for the year ended December 31, 2024, was HKD 3,364,018,000, representing a 6.1% increase from HKD 3,172,048,000 in 2023[25]. - The company reported a significant increase in overall market strategy and management, with a focus on dental technology and related production techniques[122]. Market Expansion and Strategy - The company is actively pursuing strategic acquisitions, including the acquisition of Hexa Ceram Company Limited, Thailand's largest dental laboratory, to enhance its product offerings and market coverage[20]. - The company has invested in digital workflows and proprietary dental solutions, positioning itself at the forefront of the digital transformation in the dental industry[9]. - The company aims to evolve into a comprehensive dental ecosystem by 2025, providing full support to customers and enhancing its product offerings, particularly in clear aligners[59]. - The company plans to establish a new business unit in Vietnam to serve mid to large dental clinic chains in North America, enhancing operational flexibility amid tariff challenges[51]. - The company aims to leverage digitalization trends in the dental industry to capture market share and enhance customer experience through advanced digital solutions[50]. - The company has made several landmark acquisitions, including the recent acquisition of Thailand's largest dental laboratory, Hexa Ceram, to diversify its global distribution and sales network[59]. - The company plans to strengthen its global leadership position through strategic measures, including acquisitions and partnerships, to expand its product offerings and enhance its distribution network[59]. Regional Performance - The company experienced growth in various regions, with Europe showing a double-digit increase in revenue, driven by the digitalization trend in the dental industry[29]. - In Europe, revenue amounted to HKD 1,618,436,000 for the fiscal year ending December 31, 2024, representing a 16.1% growth from HKD 1,399,371,000 in 2023, accounting for 48.1% of total revenue[50]. - North America generated revenue of HKD 752,083,000, a slight decrease of HKD 1,532,000 from HKD 753,615,000 in 2023, contributing approximately 22.3% to total revenue[51]. - The Greater China market recorded revenue of approximately HKD 662,210,000 for the year ending December 31, 2024, a decrease of about HKD 51,382,000 compared to the previous year, representing approximately 19.7% of total group revenue, down from 22.5%[55]. - The Australian market generated revenue of approximately HKD 264,752,000 for the year ending December 31, 2024, an increase of about HKD 10,411,000, accounting for approximately 7.9% of total group revenue, slightly down from 8.0%[56]. - The company reported a 30.1% increase in revenue from other markets, totaling HKD 66,537,000 compared to HKD 51,129,000 in 2023[46]. Operational Efficiency and Investments - The company has expanded its production capacity with the full operation of its Dongguan Phase II and Vietnam facilities to meet growing demand[11]. - The company is committed to sustainable growth and responsible business practices, focusing on minimizing waste and carbon emissions through digital production technologies[13]. - The company is committed to investing in digitalization to improve operational efficiency and customer experience, positioning itself at the forefront of industry integration[58]. - Research and development costs for the year were approximately HKD 43,564,000, representing about 3.1% of the group’s revenue, an increase from 2.4% in 2023[83]. - Capital expenditures for the year ended December 31, 2024, amounted to approximately HKD 153,504,000, with investments in cutting-edge technology machinery totaling approximately HKD 59,207,000, up from HKD 32,862,000 in 2023[83]. Financial Management and Governance - The group’s debt ratio as of December 31, 2024, was approximately 14%, a decrease from 16% in 2023, indicating a stable financial condition[87]. - The group has significant goodwill and intangible assets, which account for a major portion of total assets, with key assumptions for impairment testing remaining stable[104]. - The group has a diversified customer base, reducing the concentration of credit risk, as it only engages with reputable third parties[109]. - The management team has over 30 years of experience in the dental industry, contributing to the company's strategic planning and operational management[125]. - The company is committed to maintaining high standards of corporate governance through its independent board members[130]. - The board of directors includes experienced professionals with extensive backgrounds in dental and corporate governance, ensuring effective oversight and strategic direction[142]. Shareholder Information and Dividends - The company proposed a final dividend of HKD 0.092 per share for the year ended December 31, 2024, up from HKD 0.090 in 2023, pending shareholder approval[26]. - The company reported a mid-term dividend of HKD 0.08 per share for the six months ending June 30, 2024, an increase from HKD 0.06 for the same period in 2023[150]. - As of December 31, 2024, the company's distributable reserves were approximately HKD 320.27 million, down from HKD 397.84 million in 2023[158]. - The company will hold its annual general meeting on May 29, 2025, with a cutoff for share transfer registration from May 26 to May 29, 2025[151]. Risks and Challenges - Geopolitical risks and trade disputes are noted as factors that could complicate the global economic outlook, affecting the group's operations and supply chain[103]. - The group faces various foreign exchange risks, particularly with currencies such as RMB, EUR, AUD, and USD, and actively monitors these risks to maintain them at acceptable levels[108]. - The budgeted sales growth rate for 2024 is projected to be between 0% to 10%, consistent with the previous year[104].

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期： 2025年4月23日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 03600 | 說明 股份回購 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行 ...

FF305 呈交日期： 2025年4月22日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 03600 | 說明 股份回購 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | 已發行股份（不包括庫存股份）變動 | 佔有關事件前的現有已發 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 | 行股份（不包括庫存股 | 庫存股份數目 | | | | | | 目 | 份）數目百分比 (註3) | | | | | 於下列日期開始 ...

表格類別： 股票 狀態： 新提交 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 公司名稱： 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期： 2025年4月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 03600 | 說明 | 股份回購 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期： 2025年4月16日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | | 是 | | | 證券代號 (如上市) | 03600 | 說明 | 股份回購 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 佔有關事件前的現有已發 ...

Summary of Conference Call Records Company Overview - The company discussed is Modern Dental, a leader in the dental industry, particularly in the field of dental prosthetics, which are primarily customized products [1][3][4]. Key Points and Arguments Industry Position and Business Model - Modern Dental operates in a fast-paced dental industry, serving dental professionals such as dentists and dental clinics [1]. - The company has established a strong relationship with dental professionals, facilitating daily communication and service delivery [2]. - Modern Dental's competitive advantage lies in its ability to produce customized products at scale, making it a unique leader in the industry [3]. Digital Transformation - The dental industry is undergoing a significant transformation due to digitalization, which raises service standards and operational efficiency [4]. - Modern Dental is transitioning from a product-focused company to a comprehensive service provider, enhancing dentists' capabilities through digital solutions [4][10]. Financial Performance - The company reported a revenue growth of approximately 6% for the year 2024, reaching HKD 33.1 billion, with a gross margin of around 53.5% [7][22]. - Adjusted EBITDA for the year was HKD 7.4 billion, with a return on equity of 15.3% [8][22]. - Core business profits increased by about 8%, with basic earnings per share reaching HKD 4.32 [8]. Market Expansion and Acquisitions - The company has expanded its market presence in Southeast Asia, including a recent acquisition in Thailand, which is expected to contribute an additional 6-7% to revenue by 2025 [2][21][23]. - The acquisition of a leading Thai company was completed at a PE ratio of approximately 10x, indicating a strategic investment for future growth [23]. Regional Performance - Australia showed the highest growth at 16% in local currency, attributed to strong digital capabilities and market leadership [10][11]. - The Greater China region experienced a modest growth of 3%, while Hong Kong faced a significant decline of 19.7% due to price competition with mainland China [18][19]. Response to Economic Conditions - Modern Dental's business is relatively insulated from economic fluctuations, with stable demand for dental services regardless of broader economic conditions [5]. - The company has a robust cash conversion capability, with over HKD 800 million in cash reserves, allowing it to navigate various market conditions effectively [7][33]. Challenges and Strategic Responses - The company is addressing challenges posed by tariffs and trade tensions, particularly in North America, where 75% of sales come from locally produced services [13][14][38]. - Modern Dental has a flexible business model that allows it to adapt to changing market conditions and manage costs effectively [15][16]. Future Outlook - The company is optimistic about maintaining high single-digit revenue growth in the coming years, supported by ongoing digitalization and market expansion efforts [21][30]. - Modern Dental aims to enhance its cash generation and shareholder returns through share buybacks and strategic investments [33][34]. Additional Important Information - The digitalization trend in the dental industry is expected to increase penetration rates significantly, with projections of reaching 50-70% in the next few years [29][30]. - The company emphasizes the importance of its distribution and sales networks, which are critical assets in maintaining competitive advantages in the market [9][10]. This summary encapsulates the key insights from the conference call, highlighting Modern Dental's strategic positioning, financial performance, market dynamics, and future growth prospects.